High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II

Published:2013-09-05 Issue:11 Volume:58 Page:728-733
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Ahn So Yoon,Chang Yun Sil,Sung Dong Kyung,Ko Ah-ra,Kim Chi Hwa,Yoo Dong Kyeom,Lim Keun Ho,Sohn Young Bae,Jin Dong Kyu,Park Won Soon

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/jhg201392.pdf

Reference18 articles.

1. Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Munoz, V. et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121, e377–e386 (2008).

2. Cho, Y. S., Kim, J. H., Kim, T. W., Chung, S. C., Chang, S. A. & Jin, D. K. Otologic manifestations of Hunter syndrome and their relationship with speech development. Audiol Neurootol 13, 206–212 (2008).

3. Jung, S. C., Park, E. S., Choi, E. N., Kim, C. H., Kim, S. J. & Jin, D. K. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy. Mol. Cells. 30, 13–18 (2010).

4. Lee, J. H., Choe, Y. H., Kim, S. J., Paik, K. H. & Jin, D. K. Changes in glycogen and glycosaminoglycan levels in hepatocytes of iduronate-2-sulfatase knockout mice before and after recombinant iduronate-2-sulfatase supplementation. Yonsei. Med. J. 52, 263–267 (2011).

5. Hong, S. H., Chu, H., Kim, K. R., Ko, M. H., Kwon, S. Y., Moon, I. J. et al. Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II. Am. J. Med. Genet. A. 158A, 2131–2138 (2012).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in MPS I and MPS II Disease Manifestations;International Journal of Molecular Sciences;2021-07-23

2. Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease);Current Pharmaceutical Design;2020-11-27

3. The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II);International Journal of Environmental Research and Public Health;2020-09-10

4. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients;International Journal of Molecular Sciences;2020-07-22

5. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment;International Journal of Molecular Sciences;2020-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3